《復牌公告》中國生物科技服務(08037.HK)附屬獲注資合共1億人幣發展創新免疫細胞治療
中國生物科技服務(08037.HK)公佈,間接非全資附屬上海隆耀與江蘇省如東高新技術產業開發區管委會及深圳前海海潤國際併購基金管理訂立無法律約束力之合作意向協議,上述投資者將投資於上海隆耀將設立之新附屬公司,從事創新免疫細胞治療之研究和開發,並於中國江蘇省如東高新技術產業開發區爲該附屬公司設立研發及生產基地。
根據協議,管委會將會爲上海隆耀提供相關之政策支持,包括租金減免如五年免租期及有優先排他租賃權可續訂租約、裝修補貼、設備補貼以用於研發、檢測、生產、支持及其他設備、研究和開發經費扶持、稅收補助、人才激勵以及其他公佈之政策。管委會主導之產業基金擬投資5,000萬元人民幣(下同)於該附屬,其中3,000萬元爲債權投資,另外2,000萬元爲股權投資。本輪投資的投前估值暫定爲12億元。另外海潤亦擬投資5,000萬元於該附屬公司作爲股權投資。
公司並申請今早起復牌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.